Department of Human Genetics 855, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Cell Oncol (Dordr). 2012 Jun;35(3):139-47. doi: 10.1007/s13402-012-0083-7.
The first joint meeting of the International Society for Cellular Oncology (ISCO) and the European Workshop on Cytogenetics and Molecular Genetics of Solid Tumors (EWCMST), organized by Bauke Ylstra, Juan Cigudosa and Nick Gilbert, was held from 4 to 8 March, 2012 in Palma de Mallorca, Spain. This meeting provided a novel and unique opportunity to jointly present the latest updates on the genetics of cancer and its implications for diagnosis, prognosis and therapy, now and in the future. Various aspects were highlighted, including the identification of effective therapeutic targets, the role of cellular senescence in tumor development and therapy, chromosome translocations in leukemias and solid tumors, mechanisms underlying fragile sites and chromosome instability, tumor-associated 'omics' landscapes, genetic and epidemiologic risk factors, the role of tissue and cancer stem cells, angiogenesis and the tumor micro-environment, and the epigenetics of cancer. In this report, new insights and clinical advancements related to these various topics are provided, based on information presented at the meeting.
由 Bauke Ylstra、Juan Cigudosa 和 Nick Gilbert 组织的国际细胞肿瘤学会(ISCO)和欧洲实体瘤细胞遗传学和分子遗传学研讨会(EWCMST)的第一次联席会议于 2012 年 3 月 4 日至 8 日在西班牙帕尔马马洛卡举行。本次会议提供了一个新颖而独特的机会,共同介绍癌症遗传学的最新进展及其对诊断、预后和治疗的影响,无论是现在还是未来。强调了各个方面,包括有效治疗靶点的鉴定、细胞衰老在肿瘤发生和治疗中的作用、白血病和实体瘤中的染色体易位、脆性位点和染色体不稳定性的机制、肿瘤相关的“组学”景观、遗传和流行病学风险因素、组织和癌症干细胞的作用、血管生成和肿瘤微环境以及癌症的表观遗传学。在本报告中,根据会议上呈现的信息,提供了与这些不同主题相关的新见解和临床进展。